Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) have been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year price […]
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) have been given an average recommendation of “Moderate Buy” by the six research firms that are presently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month […]
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) have earned a consensus rating of “Moderate Buy” from the six ratings firms that are presently covering the company, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 […]
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Rating) was the target of a significant increase in short interest in May. As of May 31st, there was short interest totalling 300 shares, an increase of 200.0% from the May 15th total of 100 shares. Based on an average daily volume of 400 shares, the short-interest ratio is […]
Shares of Hikma Pharmaceuticals PLC (LON:HIK – Get Rating) have been given an average rating of “Moderate Buy” by the six brokerages that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12 month target […]